Oxford BioMedica
Matthew Saxon is a Senior Proposals Associate at Oxford Biomedica, a position held since May 2025, following a role as a Scientific Training Specialist at Cell and Gene Therapy Catapult. Relevant experience includes extensive work in various analytical roles at Oxford Biomedica from 2018 to 2023, focusing on the development and implementation of analytical methods for gene therapy products. Education includes a Bachelor of Science in Biology from the University of York, complemented by research and internship experiences at notable institutions such as the University of York, Green Biologics Ltd., and the Max Planck Institute for Molecular Genetics. Matthew Saxon has demonstrated a strong ability to foster partnerships and engage stakeholders in the biotechnology and advanced therapy sectors.
This person is not in any teams
This person is not in any offices
Oxford BioMedica
2 followers
Oxford Biomedica (LSE: OXB) is a leading, fully integrated, cell and gene therapy group.